Gut

Papers
(The TQCC of Gut is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms888
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19756
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection660
Mucus barrier, mucins and gut microbiota: the expected slimy partners?628
Gut microbiome and health: mechanistic insights583
Gut microbiota-derived metabolites as central regulators in metabolic disorders464
Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries426
Interaction between drugs and the gut microbiome413
Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process359
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications339
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites338
Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report302
A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice279
Global burden of oesophageal and gastric cancer by histology and subsite in 2018272
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort269
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus265
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study257
Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake257
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome249
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)244
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19240
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN237
Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health231
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases225
Faecal calprotectin indicates intestinal inflammation in COVID-19222
Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome219
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus213
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals213
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents213
Effect of IBD medications on COVID-19 outcomes: results from an international registry210
COVID-19 and immunomodulation in IBD209
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic205
Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis201
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD196
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome195
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19190
Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis182
The role of gut microbiota in cancer treatment: friend or foe?178
Albumin in decompensated cirrhosis: new concepts and perspectives171
Advances in non-invasive assessment of hepatic fibrosis165
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis163
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension163
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting162
Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study160
Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superior159
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) imm158
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19157
COVID-19 and the gastrointestinal tract: more than meets the eye155
Guidelines on the management of ascites in cirrhosis155
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology152
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial150
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores148
Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching148
Calprotectin: from biomarker to biological function145
Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing144
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort144
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab142
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients139
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups139
Helicobacter pyloriresistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community138
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications134
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility134
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis131
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning125
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model125
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients125
Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes122
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis120
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease119
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges118
Diet quality and risk and severity of COVID-19: a prospective cohort study118
Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn116
Six-month follow-up of gut microbiota richness in patients with COVID-19113
COVID-19 in an international European liver transplant recipient cohort113
F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer112
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study112
Low risk of COVID-19 transmission in GI endoscopy111
Big data in IBD: big progress for clinical practice110
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide110
Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial108
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies106
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic102
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?102
Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis102
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives101
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19101
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation100
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis100
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series98
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-1997
Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study97
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer96
Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis95
A faecal microbiota signature with high specificity for pancreatic cancer94
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma94
Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade93
Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma89
Artificial intelligence and colonoscopy experience: lessons from two randomised trials89
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury89
Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence89
Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure89
Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL1688
COVID-19 in gastroenterology: a clinical perspective86
Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women85
Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription84
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic func83
Lactobacillus gallinarummodulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis83
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort83
Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies82
British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults82
Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population81
Recent advances in clinical practice: epidemiology of autoimmune liver diseases81
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis80
Novel therapeutic targets for cholestatic and fatty liver disease79
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification78
Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice77
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism77
Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachnospiraceae77
Targeting the gut-liver-immune axis to treat cirrhosis77
Machine learning in GI endoscopy: practical guidance in how to interpret a novel field77
Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning76
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover76
Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment76
Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging75
Disrupted spermatogenesis in a metabolic syndrome model: the role of vitamin A metabolism in the gut–testis axis75
Involvement of liver in COVID-19: systematic review and meta-analysis75
Cirrhosis as new indication for statins74
Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites73
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events73
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies73
Piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions: a retrospective comparison across two successive periods73
Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis72
Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial72
Blue poo: impact of gut transit time on the gut microbiome using a novel marker72
Current therapies and new developments in NASH71
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes71
Liquid biopsy in the clinical management of hepatocellular carcinoma71
Long-term yield of pancreatic cancer surveillance in high-risk individuals69
ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multicentre study68
Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts68
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis67
Loss of hepatic Mboat7 leads to liver fibrosis65
High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells65
Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)65
Improvement in sperm quality and spermatogenesis following faecal microbiota transplantation from alginate oligosaccharide dosed mice65
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis64
Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity64
Mitochondrial dysfunction during loss of prohibitin 1 triggers Paneth cell defects and ileitis64
Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom64
Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial62
Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis62
25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future62
Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score60
Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis60
Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett’s oesophagus and provides insights into clinical heterogeneity in reflux d60
Estimating the environmental impact of disposable endoscopic equipment and endoscopes59
Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers59
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer59
Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate59
SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study58
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial58
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update57
ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1–TFAM signalling in alcoholic steatohepatitis56
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer56
Advancing human gut microbiota research by considering gut transit time56
Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet56
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis56
Chinese Consensus Report on Family-BasedHelicobacter pyloriInfection Control and Management (2021 Edition)55
Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea55
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis55
CXCR2 inhibition enables NASH-HCC immunotherapy55
Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder55
Equivalent performance of single-use and reusable duodenoscopes in a randomised trial55
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma54
Proton pump inhibitors and risk of gastric cancer: population-based cohort study54
Severe liver failure during SARS-CoV-2 infection54
Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population53
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma53
Long-term outcomes after endoscopic treatment for Barrett’s neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period53
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study52
Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study52
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size52
Mass eradication ofHelicobacter pylorito reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands52
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms51
Location-specific cell identity rather than exposure to GI microbiota defines many innate immune signalling cascades in the gut epithelium51
Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health51
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study51
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease51
Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial50
PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF50
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis49
Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis49
Multiomics analysis reveals the presence of a microbiome in the gut of fetal lambs49
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma49
Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)48
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice48
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance48
Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulce48
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny47
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers47
Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance47
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes47
N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression47
YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition47
Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis46
Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health46
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer46
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world46
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy46
British Society of Gastroenterology guidelines on the management of functional dyspepsia46
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation45
Niche-specific functional heterogeneity of intestinal resident macrophages45
Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men45
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity45
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles45
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma45
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression44
Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism44
Genomic evolution and diverse models of systemic metastases in colorectal cancer44
COVID-19 and liver disease44
Detection of Barrett’s oesophagus through exhaled breath using an electronic nose device43
Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer43
COVID-19 infection in Crohn’s disease under treatment with adalimumab43
Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions43
Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study43
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM242
Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts42
Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis42
Oncogenetic landscape of lymphomagenesis in coeliac disease42
Rapid resolution of COVID-19 after faecal microbiota transplantation42
Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care42
Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients41
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links41
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database41
Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?41
Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study40
Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health40
Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor40
GI symptoms as early signs of COVID-19 in hospitalised Italian patients40
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies40
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment40
Safely restarting GI endoscopy in the era of COVID-1939
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer39
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System38
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells38
From the origin of NASH to the future of metabolic fatty liver disease38
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients38
Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource38
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS38
Genetic architectures of proximal and distal colorectal cancer are partly distinct38
0.020616054534912